Schedule 13G ownership disclosure

ARRAY BIOPHARMA INC

Security class unavailable · CUSIP: 04269X105

Event date: 2015-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,396,573
Percent of class
10.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001425738-15-000019
Form type
SC 13G/A
Filer
ARRAY BIOPHARMA INC
CIK
CIK 1100412
Filed
Sep 10, 2015
Reporting period
Aug 05, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub